T1	Participants 119 130	31 patients
T2	Participants 337 348	15 patients
T3	Participants 376 390	16 tinidazole,
T4	Participants 412 420	2 groups
T5	Participants 581 598	12 of 15 patients
T6	Participants 695 712	15 of 16 patients
